OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

Clear
Clear
Clear
Clear
Clear
Clear
Clear
Organization: University of California, San Diego

8 Projects | 5 Researchers | $1,362,004 Invested

2019

University of California, San Diego

Douglas Galasko, MD

TABLOOD: a biomarker panel for direct assessment in blood of Alzheimer’s Disease pathophysiological hallmarks.

  • Funding Amount: $125,000
  • Organization Type: Academic/Nonprofit
  • Program: Diagnostics Accelerator
  • Target: Tau
  • Status: Closed

2012

University of California, San Diego

Douglas Galasko, MD

Development of synaptic biomarkers related to AMPA-receptor trafficking in Alzheimer's Disease

  • Funding Amount: $140,000
  • Organization Type: Academic/Nonprofit
  • Program: Clinical
  • Target: Synaptic Activity and Neurotransmitters
  • Status: Closed

2008

University of California, San Diego

Mark Tuszynski, MD, PhD

Preventing Neuronal Loss in the Non-Human Primate Cortex

  • Funding Amount: $50,000
  • Organization Type: Academic/Nonprofit
  • Program: Clinical
  • Status: Closed

2007

University of California, San Diego

Nazneen Dewji, PhD

Novel Therapeutic Approaches for the Treatment of Alzheimer's Disease

  • Funding Amount: $75,000
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Status: Closed

2006

University of California, San Diego

Corinne Jolivalt, PhD

Effect of diabetes on Alzheimer's disease progression and efficacy of disease-specific treatments

  • Funding Amount: $70,000
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Status: Closed

2006

University of California, San Diego

Preventing Neuronal Loss in the Non-Human Primate Cortex

  • Funding Amount: $100,000
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Status: Closed

2000

University of California, San Diego

A Phase I Study of Nerve Growth Factor Ex Vivo Gene Therapy for Alzheimer's Disease

  • Funding Amount: $402,113
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Status: Closed

1999

University of California, San Diego

Leon Thal, MD

Utility of MRI to Predict Progression from MCI to AD and Treatment Response to Vitamin E and Donepezil

  • Funding Amount: $399,891
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Status: Closed